CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsHigh earnings quality
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.36%Below 5Y avg (0.69%)
Annual Rate
CNY 0.03Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.05BCNY604.46M · vs all stocks (USD)
Revenue (TTM)
388.64MCNY57.99M · vs all stocks (USD)
Profit Margin
-45.51%Beta
0.2340xvs all stocks
52-Week Change
-28.36%vs all stocks
Market Capitalization
4.05BCNY604.46M · vs all stocks (USD)
Enterprise Value
2.61BCNY389.73M · vs all stocks (USD)
Price to Sales (TTM)
10.42xPrice to Book (MRQ)
1.26xEnterprise to Revenue
6.72xEnterprise to EBITDA
130.78xGross Margin
67.58%Profit Margin
-45.51%Operating Margin
-12.89%Return on Assets (TTM)
-0.45%Return on Equity (TTM)
-5.52%Revenue (TTM)
388.64MCNY57.99M · vs all stocks (USD)
Revenue per Share (TTM)
0.7990CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-13.40%Gross Profit (TTM)
252.25MCNY37.64M · vs all stocks (USD)
EBITDA (TTM)
68.19MCNY10.18M · vs all stocks (USD)
Net Income (TTM)
-176.89MCNY-26.40M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-2.43%Operating Cash Flow (TTM)
9.14MCNY1.36M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-59.80MCNY-8.92M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0300CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.36%vs all stocks
5-Year Average Dividend Yield
0.69%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
21.47MCNYFY2025 · Dec 31, 2025Revenue
404.72MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
141.19MCNYFY2025 · Dec 31, 2025Gross Profit
263.53MCNYFY2025 · Dec 31, 2025Operating Income
-8.87MCNY-1.32M · vs all stocks (USD)
Pre-tax Income
12.30MCNYFY2025 · Dec 31, 2025Income Tax Expense
4.51MCNYFY2025 · Dec 31, 2025Net Income
7.79MCNYFY2025 · Dec 31, 2025EBIT
12.76MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
68.19MCNYFY2025 · Dec 31, 2025Research & Development
69.51MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
152.34MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.29MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
454.54KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
485.70MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
485.70MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
7.79MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.78MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
3.45MCNYFY2025 · Dec 31, 2025Free Cash Flow
-96.66MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
75.82MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
7.79MCNYFY2025 · Dec 31, 2025Other Non-cash Items
100.92KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-12.40MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
7.96MCNYFY2025 · Dec 31, 2025Capital Expenditures
-100.10MCNYFY2025 · Dec 31, 2025Sale of Investments
91.45MCNYFY2025 · Dec 31, 2025Other Investing Activity
-37.07MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-45.73MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
19.99MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-250.89KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
19.74MCNYFY2025 · Dec 31, 2025Shares Outstanding
481.67MSharesUpdated Sep 20, 2026Float Shares
210.95MSharesUpdated Sep 20, 2026% Held by Insiders
58.17%vs all stocks
% Held by Institutions
0.55%vs all stocks
Total Cash (MRQ)
1.47BCNY219.73M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.06CNYUpdated Sep 20, 2026Total Debt (MRQ)
14.26MCNY2.13M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0044xCurrent Ratio (MRQ)
21.23xBook Value per Share (MRQ)
6.67CNYUpdated Sep 20, 2026Total Assets
3.57BCNY532.48M · vs all stocks (USD)
Total Current Assets
1.69BCNYFY2025 · Dec 31, 2025Total Liabilities
175.95MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.88BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
83.66MCNYFY2025 · Dec 31, 2025Total Current Liabilities
92.30MCNYFY2025 · Dec 31, 2025Cash
61.58MCNYFY2025 · Dec 31, 2025Cash Equivalents
26.56MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
88.13MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.47BCNYFY2025 · Dec 31, 2025Accounts Receivable
42.40MCNYFY2025 · Dec 31, 2025Inventory
68.85MCNYFY2025 · Dec 31, 2025Accounts Payable
22.63MCNYFY2025 · Dec 31, 2025Short-term Debt
19.86MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.03MCNYFY2025 · Dec 31, 2025Common Stock (Book)
481.67MCNYFY2025 · Dec 31, 2025Retained Earnings
1.80BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.39BCNY506.22M · vs all stocks (USD)
52-Week Low
7.77CNYUpdated Sep 20, 202652-Week High
13.80CNYUpdated Sep 20, 202652-Week Change
-28.36%vs all stocks
Beta
0.2340xvs all stocks
50-Day MA
9.14CNYUpdated Sep 20, 2026200-Day MA
10.21CNYUpdated Sep 20, 2026Avg 10-Day Volume
3.78MSharesUpdated Sep 20, 2026Avg 30-Day Volume
8.25MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.3700CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.68Profit Margin: -0.46
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.64
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
476830
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Xiao Feng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Miracure Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hefei Lifeon Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Qianjiang Yongan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shattuck Labs Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jinling Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Genfit S.A.
Tier 1ProductionApproval-Gated PipelineRuleRisk